Page 1 | Search Results | Hematology, ASH Education Program

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management

Oyebimpe O. Adesina, Lynne D. Neumayr

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 351–358.

https://doi.org/10.1182/hematology.2019000038

Published: 2019

Journal Articles

Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease

Charles T. Quinn

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 438–443.

https://doi.org/10.1182/asheducation-2014.1.438

Published: 2014

Journal Articles

Pharmacogenomics of antiplatelet drugs

Marc S. Sabatine, Jessica L. Mega

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 343–347.

https://doi.org/10.1182/asheducation-2014.1.343

Published: 2014

Journal Articles

Coagulation in the Pathophysiology of Hemolytic Anemias

Maria Domenica Cappellini

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 74–78.

https://doi.org/10.1182/asheducation-2007.1.74

Published: 2007

Journal Articles

New Anticoagulants

Kenneth A. Bauer

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 450–456.

https://doi.org/10.1182/asheducation-2006.1.450

Published: 2006

Journal Articles

Consultations on Patients with Venous or Arterial Diseases

Barbara M. Alving, Charles W. Francis, William R. Hiatt, Mark R. Jackson

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 540–558.

https://doi.org/10.1182/asheducation-2003.1.540

Published: 2003

Journal Articles

Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy

Thomas A. Waldmann, Ronald Levy, Barry S. Coller

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 394–408.

https://doi.org/10.1182/asheducation.V2000.1.394.394

Published: 2000

NARROW

Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management

Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease

Pharmacogenomics of antiplatelet drugs

Coagulation in the Pathophysiology of Hemolytic Anemias

New Anticoagulants

Consultations on Patients with Venous or Arterial Diseases

Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy

ASH Publications

American Society of Hematology

Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management

Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease

Pharmacogenomics of antiplatelet drugs

Coagulation in the Pathophysiology of Hemolytic Anemias

New Anticoagulants

Consultations on Patients with Venous or Arterial Diseases

Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only